Newsfeeds - Spark Newswire

3 minute read

FDA
News

Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial Of Milademetan For De-Differentiated Liposarcoma

July 20, 8:05 AM

Rain Therapeutics Inc., a clinical-stage company developing precision oncology therapeutics, today announced that the first patient has been randomized in the multicenter, open-label, Phase 3 registrational study

RAIN

3 minute read

The Past Week’s Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More

By Nelson Hem

July 11, 5:10 PM

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Initial and secondary public offerings enticed insiders to come out and buy shares this past week. Besides IPOs, biotechs and special purpose acquisition companies are well represented on this week's list.

ABOS

5 minute read

Uncategorized

54 Biggest Movers From Yesterday

By Lisa Levin

May 26, 4:55 AM

Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.

ACHV

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

May 15, 9:48 AM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

May 14, 7:59 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

3 minute read

Uncategorized

Last Week’s Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More

By Nelson Hem

May 2, 8:05 AM

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public share offerings to add or bolster stakes. Again, biotechnology companies are well represented on this list.

AMEH

Latest news

Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial Of Milademetan For De-Differentiated Liposarcoma

The Past Week’s Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More

54 Biggest Movers From Yesterday

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

Last Week’s Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More